Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

14 treatments under study, led by Sleep Study

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results50% success

Data Visualizations

Phase Distribution

2Total
Phase 1 (1)
Phase 2/3 (1)

Trial Status

Completed1
Terminated1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT00581477Phase 2/3Terminated

Treatment of Orthostatic Hypotension

NCT00748059Phase 1Completed

The Pathophysiology of Orthostatic Hypotension

Showing all 2 trials

Research Network

Common Treatments

  • Sleep Study1
  • Bicycle Exercise Test1
  • Standing Or Upright Tilt1
  • Brain Function Studies1
  • Bodpod1

Active Sponsors

  • Vanderbilt University1
  • Vanderbilt University Medical Center1
  • National Heart, Lung, and Blood Institute (NHLBI)1

Top Investigators

Related Conditions

  • Autonomic Nervous System Diseases2
  • Orthostatic Hypotension2
  • Orthostatic Intolerance2

Activity Timeline